Stare Babice, Poland

Janusz Obukowicz

This inventor holds 1 USPTO granted patent. Top assignee: Bs-154 S.p. Zo.o.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janusz Obukowicz. Retrieved from https://idiyas.com/inventor/janusz-obukowicz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Janusz Obukowicz: Innovator in Cytostatics

Introduction

Janusz Obukowicz is a notable inventor based in Stare Babice, Poland. He has made significant contributions to the field of cytostatics, particularly through his innovative research and development of new chemical compounds.

Latest Patents

Obukowicz holds a patent for "Asymmetrically substituted anthrapyridazone derivatives as cytostatics." This invention pertains to new, asymmetrically substituted derivatives of 2,7-dihydro-3H-dibenzo[de,h]cinnoline-3,7-dione. These derivatives exhibit activity against tumor cells, especially those with multidrug resistance (MDR). The invention is represented by a general formula (I), highlighting its potential in cancer treatment.

Career Highlights

Throughout his career, Janusz Obukowicz has focused on the development of innovative solutions in the pharmaceutical field. His work has led to advancements in the treatment of cancer, showcasing his dedication to improving patient outcomes through scientific research.

Collaborations

Obukowicz has collaborated with notable colleagues, including Edward Borowski and Barbara J. Stefanska. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Janusz Obukowicz is a distinguished inventor whose work in cytostatics has the potential to make a significant impact in the fight against cancer. His innovative approach and dedication to research continue to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…